
Bajaj Healthcare Ltd is Rated Strong Sell
2026-03-31 10:10:37Bajaj Healthcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Bajaj Healthcare Ltd is Rated Strong Sell
2026-03-20 10:10:45Bajaj Healthcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Bajaj Healthcare Ltd Stock Hits 52-Week Low at Rs.273.15
2026-03-16 11:37:43Bajaj Healthcare Ltd’s shares declined sharply to a new 52-week low of Rs.273.15 on 16 Mar 2026, marking a significant downturn amid a six-day losing streak that has seen the stock shed 12.6% of its value. This fresh low underscores ongoing pressures on the micro-cap pharmaceutical company, which continues to underperform both its sector and the broader market indices.
Read full news article
Bajaj Healthcare Ltd Stock Hits 52-Week Low at Rs.293 Amid Continued Downtrend
2026-03-13 10:08:52Bajaj Healthcare Ltd’s shares declined to a fresh 52-week low of Rs.293 on 13 Mar 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical and biotechnology company’s stock has underperformed both its sector and the broader market, reflecting persistent pressures on its valuation and market sentiment.
Read full news article
Bajaj Healthcare Ltd Stock Hits 52-Week Low at Rs 300.6
2026-03-12 11:06:30Bajaj Healthcare Ltd’s shares declined to a fresh 52-week low of Rs.300.6 on 12 Mar 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical and biotechnology company’s stock has underperformed both its sector and broader market indices, reflecting persistent pressures on its valuation and market sentiment.
Read full news article
Bajaj Healthcare Ltd Stock Falls to 52-Week Low of Rs 306.75
2026-03-09 13:39:18Bajaj Healthcare Ltd’s shares declined sharply to a new 52-week low of Rs.306.75 on 9 March 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical and biotechnology company’s stock underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance and valuation metrics.
Read full news article
Bajaj Healthcare Ltd is Rated Strong Sell
2026-03-09 10:10:56Bajaj Healthcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 09 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Bajaj Healthcare Ltd is Rated Strong Sell
2026-03-08 10:10:38Bajaj Healthcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Bajaj Healthcare Ltd Stock Hits 52-Week Low at Rs 312.05
2026-03-04 12:06:11Bajaj Healthcare Ltd’s shares declined to a fresh 52-week low of Rs.312.05 on 4 March 2026, marking a significant milestone in the stock’s downward trajectory amid broader market fluctuations and company-specific performance factors.
Read full news articleCorporate Actions
No Upcoming Board Meetings
Bajaj Healthcare Ltd has declared 20% dividend, ex-date: 19 Sep 25
Bajaj Healthcare Ltd has announced 5:10 stock split, ex-date: 28 Sep 21
Bajaj Healthcare Ltd has announced 1:1 bonus issue, ex-date: 09 Apr 19
No Rights history available






